In contrast to C27 and C32, the C29 (CD56+, CD16+, CD57+, CD28+) cluster was lower in patients with PD (Fig. 3i, j), although no significant difference was observed using ANOVA between the four subgroups in C29 (Supplementary Fig. 3j). This evidence concerns the gene NCAM1 and Parkinson disease.